Showing results (71-80 of 208) with videos related to
Sort By:
Pageof 21
Physiological Reports|April 4, 2018
Effects of sildenafil, metformin, and simvastatin on ADH-independent urine concentration in healthy volunteersAnneke P Bech, Jack F M Wetzels, Tom NijenhuisNeuropsychobiology|January 1, 1976
Cyclic AMP levels in cerebrospinal fluid in manic-melancholic patientsA Geisler, P Bech, M Johannesen, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1991
Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic responseR Rosenberg, P Bech, M Mellergård, et al.Psychopharmacology|August 20, 2002
Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depressionP Bech, P Tanghøj, H F Andersen, et al.Psychopathology|January 1, 1984
World Health Organization Schedule for Standardized Assessment of Depressive Disorders (WHO/SADD-5). Item combinations and interobserver reliabilityP Bech, A Gjerris, J Andersen, et al.Physiological Reports|December 8, 2017
Reference values of renal tubular function tests are dependent on age and kidney functionAnneke P Bech, Jack F M Wetzels, Tom NijenhuisActa Psychiatrica Scandinavica. Supplementum|January 1, 1991
Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatmentR Rosenberg, P Bech, M Mellergård, et al.Acta Psychiatrica Scandinavica|June 22, 2010
Dose-response relationship of sertindole and haloperidol using the pharmacopsychometric triangleP Bech, P Tanghøj, K Andreasson, et al.European Journal of Clinical Pharmacology|January 1, 1986
Steady-state levels of imipramine and its metabolites: significance of dose-dependent kineticsK Brøsen, L F Gram, R Klysner, et al.Journal of Psychiatry & Neuroscience : JPN|July 1, 1997
Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. The Canadian Remoxipride GroupA G Awad, Y D Lapierre, C Angus, et al.Pageof 21